エピソード

  • Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases

    Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases
    2025/08/22

    Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for patients with limited-stage and extensive-stage small cell lung cancer.

    CME information and select publications here.

    続きを読む 一部表示
    58 分
  • Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm

    Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
    2025/08/20

    Dr Shannon Westin from the University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for ovarian and endometrial cancer.

    CME information and select publications here.

    続きを読む 一部表示
    53 分
  • Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

    Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
    2025/08/15

    Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.

    CME information and select publications here.

    続きを読む 一部表示
    18 分
  • Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma

    Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma
    2025/08/14

    For this patient-focused webinar, medical oncologist Dr Neil Love is joined by Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Sagar Lonial from the Winship Cancer Institute of Emory University in Atlanta, Georgia, to discuss the patient experience associated with the diagnosis and treatment of relapsed/refractory multiple myeloma.

    Educational and faculty information here.

    続きを読む 一部表示
    1 時間 2 分
  • Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations

    Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
    2025/08/11

    Dr Jorge Cortes from Georgia Cancer Center at Augusta University discusses patient cases and summarizes current treatment approaches for FLT3- and IDH1/2-mutant acute myeloid leukemia.

    CME information and select publications here.

    続きを読む 一部表示
    43 分
  • Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

    Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
    2025/08/07

    Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.

    CME information and select publications here.

    続きを読む 一部表示
    59 分
  • Multiple Myeloma — Optimizing the Selection of First-Line Therapy

    Multiple Myeloma — Optimizing the Selection of First-Line Therapy
    2025/08/06

    Prof Xavier Leleu and Dr Peter Voorhees review relevant clinical data regarding first-line treatment decisions for patients with multiple myeloma.

    CME information and select publications here.

    続きを読む 一部表示
    57 分
  • Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

    Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
    2025/08/01

    Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data and shares clinical investigator perspectives on the role of TROP2-directed antibody-drug conjugates in the management of HR-positive and triple-negative breast cancers.

    CME information and select publications here.
    続きを読む 一部表示
    20 分